Canaccord analyst Matt Bottomley upgraded Aurora Cannabis to Buy from Hold with an unchanged price target of C$0.80.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACB:
- Options Volatility and Implied Earnings Moves Today, February 08, 2024
- Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million
- Aurora Cannabis Acquires MedReleaf Australia
- Rising High: Exclusive talk with drug manufacturer Optimi Health
- Aurora Cannabis’ Board approves plan to consolidate outstanding shares